Chronotherapy in Ulcerative Colitis

Clinical Trial Title

Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis: A Randomized Crossover Trial

Clinical Trial Protocol Description:

The purpose of this study is to evaluate if time of day administration of oral, once daily 5-ASA therapy in alignment with a patient’s circadian rhythms will improve the patient’s condition. The study will use signs of inflammation, how easily substances are absorbed into your bloodstream (gut permeability), microbiome community (the bacteria in your gut), and measured levels of 5-ASA in your blood stream to determine if time of 5-ASA administration alters a patient’s condition.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Are an adult with ulcerative colitis currently taking 5-ASA (5-Aminosalicylic Acid).

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Study Details

Clinical Trial Investigator

Garth Swanson, MD, MS

Contact Information

Alexander Yerkan